| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/04/2003 | US6528263 Identifying a cell expressing protooncogene polypeptide by contacting a nucleic acid with a polynucleotide reagent and detecting its binding; can be used in diagnosis and treatment of cancer |
| 03/04/2003 | US6528262 Hybridization of cDNA from sense RNA with cDNA obtained from antisense RNA; DNA polymerase treatment; amplification and cloning |
| 03/04/2003 | US6528261 Method for typing of HLA alleles |
| 03/04/2003 | US6528260 Biallelic markers related to genes involved in drug metabolism |
| 03/04/2003 | US6528259 Methods for detecting human methylenetetrahydrofolate reductase allelic variants |
| 03/04/2003 | US6528258 Nucleic acid sequencing using an optically labeled pore |
| 03/04/2003 | US6528257 Method for the simultaneous monitoring of individual mutants in mixed populations |
| 03/04/2003 | US6528256 Methods for identification and isolation of specific nucleotide sequences in cDNA and genomic DNA |
| 03/04/2003 | US6528254 Incubating with a nucleic acid polymerase to form duplex and single-stranded nucleic acid; cleaving with FEN(5'flap-specific) nuclease to generate a signal |
| 03/04/2003 | US6528252 Methods for identifying a protease inhibitor |
| 03/04/2003 | US6528249 Protein activity screening of clones having DNA from uncultivated microorganisms |
| 03/04/2003 | US6528247 Activation of apoptin-induced apoptosis by large T-Antigen of SV40 in normal and cancer-prone cells; can be used in diagnosis and treatment of cancer |
| 03/04/2003 | US6528064 Recombinant trytophan mutants of influenza |
| 03/04/2003 | US6528061 purified immunogenic polypeptide comprising a polysaccharide mimotope recognized by a protective monoclonal antibody having a specificity for a surface polysaccharide of a bacterium of the Shigella species, said surface polysaccharide |
| 03/04/2003 | US6528055 Polypeptide for use in the diagnosis, treatment and prevention of infections, immune response defects and autoimmune diseases |
| 03/04/2003 | US6528054 Comprise one or more breast tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions. Alternatively, a therapeutic composition may comprise an antigen presenting cell that expresses a breast |
| 03/04/2003 | US6528052 A method for in vivo, ex vivo or in vitro repair and regeneration of degenerated, diseased or injured articular cartilage or for de novo production of cartilage, collagen, ligaments, tendons or bone, said method comprising a step of |
| 03/04/2003 | US6528038 An immune response directed against Porphyromonas gingivalis. The composition includes a suitable adjuvant and/or acceptable carrier and one substantially purified P. gingivalis immunogen. The immunogen is selected from the group consisting |
| 03/04/2003 | US6527933 Biotin-tagged DNA samples are captured at the spots of avidin immoblized on filter membrane by biotin-avidin bonding |
| 03/04/2003 | CA2396887A1 Method for determining quinolon resistance of tubercle bacilli |
| 03/04/2003 | CA1341423C Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome |
| 02/28/2003 | CA2400601A1 Real-time gene quantification with internal standards |
| 02/28/2003 | CA2400531A1 Human nhe2 |
| 02/28/2003 | CA2399559A1 Method for identifying metalloenzyme inhibitors |
| 02/28/2003 | CA2356540A1 Expressed dna sequences involved in mitochondrial functions |
| 02/28/2003 | CA2356536A1 Mitochondrial dna sequence alleles |
| 02/27/2003 | WO2003017177A2 Method and system for profiling biological systems |
| 02/27/2003 | WO2003017138A1 Biological sequence information reading method and storing method |
| 02/27/2003 | WO2003017127A2 Method for modelling biochemical pathways |
| 02/27/2003 | WO2003017038A2 A molecular diagnostic and computerized decision support system for selecting the optimum treatment for human cancer |
| 02/27/2003 | WO2003016917A2 Sodium channel regulators and modulators |
| 02/27/2003 | WO2003016916A1 Identification and isolation of somatic stem cells and uses thereof |
| 02/27/2003 | WO2003016915A1 Tumor specific oligosaccharide sequences and use thereof |
| 02/27/2003 | WO2003016908A2 Genes and gene products that confer susceptibility to vancomycin derivative antibiotics and methods and assays for identifying bifunctional glycopeptide antibiotics using same |
| 02/27/2003 | WO2003016894A2 Coplanar waveguide biosensor for detecting molecular or cellular events |
| 02/27/2003 | WO2003016867A2 Method and quantification assay for determining c-kit/scf/pakt status |
| 02/27/2003 | WO2003016866A2 Method for the enumeration of mammalian micronucleated erythrocyte populations with a single-laser flow cytometer |
| 02/27/2003 | WO2003016860A2 Systems and methods for screening pharmaceutical chemicals |
| 02/27/2003 | WO2003016574A1 Analysis of gene expression profiles using sequential hybridization |
| 02/27/2003 | WO2003016573A1 Age-associated markers |
| 02/27/2003 | WO2003016571A1 Zinc finger domain libraries |
| 02/27/2003 | WO2003016570A1 METHOD OF EXAMINING LIVER CELL CANCER USING POLYMORPHISM OF IL-1β GENE |
| 02/27/2003 | WO2003016569A1 Nucleic acid amplification methods |
| 02/27/2003 | WO2003016568A2 Yeast arrays, methods of making such arrays, and methods of analyzing such arrays |
| 02/27/2003 | WO2003016567A2 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 02/27/2003 | WO2003016566A2 Improvements relating to capillary gel array analysis |
| 02/27/2003 | WO2003016565A2 Dna sequence analysis |
| 02/27/2003 | WO2003016564A2 Use of associations between at least one nucleic sequence polymorphism of the sh2 gene and at least one seed quality characteristic in plant selection methods |
| 02/27/2003 | WO2003016563A2 Novel molecular target for neurotoxicity |
| 02/27/2003 | WO2003016562A2 Compositions and methods for detecting multidrug resistant strains of m. tuberculosis having mutations in genes of the mutt family |
| 02/27/2003 | WO2003016561A2 Method for the production of cna |
| 02/27/2003 | WO2003016560A2 Methods for diagnosing and treating neoplasias using nf-at transcription factors |
| 02/27/2003 | WO2003016559A2 Method for treating diabetes based on the modulation of nh4alpha gene expression |
| 02/27/2003 | WO2003016557A1 Method and probes for the genetic diagnosis of hereditary haemochromatosis |
| 02/27/2003 | WO2003016556A1 Measurement of microbiological activity in an opaque medium |
| 02/27/2003 | WO2003016554A1 Detection of bacterial vaginosis |
| 02/27/2003 | WO2003016550A2 Compositions and methods comprising control nucleic acid |
| 02/27/2003 | WO2003016549A2 Nucleic-acid associated proteins |
| 02/27/2003 | WO2003016546A1 Method and device for simultaneously molecularly cloning and polylocus profiling of genomes or genome mixtures |
| 02/27/2003 | WO2003016542A1 Obesity related genes expressed at least in the hypothalamus |
| 02/27/2003 | WO2003016534A1 Rpob gene of streptomyces, primer specific to streptomyces, and identification method of streptomyces having rifampin resistance or sensitivity by using the same |
| 02/27/2003 | WO2003016532A1 Human protooncogene kg-20 and protein encoded therein |
| 02/27/2003 | WO2003016528A2 Oligonucleotide compositions and their use to induce apoptosis |
| 02/27/2003 | WO2003016527A2 Process for the detection of oxidative stress and kit for its implementation |
| 02/27/2003 | WO2003016522A2 Methods and compounds for the targeting of protein to exosomes |
| 02/27/2003 | WO2003016506A2 Secreted proteins |
| 02/27/2003 | WO2003016504A2 Polymorphisms associated with ion-channel disease |
| 02/27/2003 | WO2003016500A2 Human toxicologically relevant genes and arrays |
| 02/27/2003 | WO2003016499A2 Combinatorial methods for inducing cancer cell death |
| 02/27/2003 | WO2003016497A2 Molecules for disease detection and treatment |
| 02/27/2003 | WO2003016494A2 Diagnosis and treatment of vascular disease |
| 02/27/2003 | WO2003016493A2 Transporters and ion channels |
| 02/27/2003 | WO2003016492A2 Adamts13 genes and proteins and variants, and uses thereof |
| 02/27/2003 | WO2003016491A2 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma |
| 02/27/2003 | WO2003016484A2 Gleason grade 4/5 prostate cancer genes |
| 02/27/2003 | WO2003016483A2 METHOD OF LABELLING cRNAs FOR PROBING OLIGO-BASED MICROARRAYS |
| 02/27/2003 | WO2003016477A2 Insect or83b odorant receptor |
| 02/27/2003 | WO2003016476A2 Gene expression profiles in glomerular diseases |
| 02/27/2003 | WO2003016475A2 Nucleic acid and amino acid sequences involved in pain |
| 02/27/2003 | WO2003016465A2 Cell cycle regulator protein |
| 02/27/2003 | WO2003016464A2 Cancer specific oligosaccharide sequences and use thereof |
| 02/27/2003 | WO2003016354A2 Recombinant anti-plasmodium falciparum antibodies |
| 02/27/2003 | WO2003016344A2 Use of lung carcinoma antigen |
| 02/27/2003 | WO2003016333A2 Virus coat protein/receptor chimeras and methods of use |
| 02/27/2003 | WO2003016328A1 Methods for the treatment and prevention of cancer |
| 02/27/2003 | WO2003016327A1 Use of intrinsic reporters of cell signaling for high content durg profiling and toxicity screening |
| 02/27/2003 | WO2003015915A1 Solid compositions for selective adsorption from complex mixtures |
| 02/27/2003 | WO2003015810A1 Medicinal use of histone deacetylase inhibitor and method of evaluating antitumor effect thereof |
| 02/27/2003 | WO2003015768A2 Use of inhibitors of proline endopeptidase to modulate inositol (1,4,5) triphosphate concentration dependent on intracellular signal cascades |
| 02/27/2003 | WO2003015711A2 Combination motif immune stimulatory oligonucleotides with improved activity |
| 02/27/2003 | WO2003015703A2 Compositions and methods relating to novel benzodiazepine compounds and targets thereof |
| 02/27/2003 | WO2003015692A2 Crystallized glucocorticoid receptor ligand binding domain polypeptide and screening methods employing same |
| 02/27/2003 | WO2003015689A2 Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases |
| 02/27/2003 | WO2003015613A2 Molecular characteristics of non-small cell lung cancer |
| 02/27/2003 | WO2003015506A1 Propagation of human hepatoblastoma cell in non-human animals |
| 02/27/2003 | WO2003001881A3 Cell-based high-throughput screening methods |
| 02/27/2003 | WO2003001178A3 Configurable dynamic three dimensional array |
| 02/27/2003 | WO2003000417A3 Microfluidic system including a virtual wall fluid interface port for interfacing fluids with the microfluidic system |
| 02/27/2003 | WO2002103000A3 Methods for modulating gap junctions |
| 02/27/2003 | WO2002097046A3 B7 related protein-2 molecules and uses thereof |